Effect of Glucagon Like Peptide 1| (GLP1) Analogues on Obese Egyptians With and Without Diabetes

The Medical Journal of Cairo University
doi 10.21608/mjcu.2019.65613
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Egypts Presidential Specialized Council for Education and Scientific Research

Related search

Glucagon-Like Peptide Analogues for Type 2 Diabetes Mellitus

2007English

Glucagon-Like Peptide-1 Analogues and Anxiety and Abnormal Eating Behaviours in Type 2 Diabetes: A Case Report

Journal of Diabetes & Metabolism
2014English

Effect of Glycosylation on Biodistribution of Radiolabeled Glucagon-Like Peptide 1

Annals of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2011English

Glucagon-Like Peptide-1 and Satiety

Nature
Multidisciplinary
1997English

Effects of Gastric Inhibitory Polypeptide, Glucagon-Like Peptide-1 and Glucagon-Like Peptide-1 Receptor Agonists on Bone Cell Metabolism

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2017English

Racial Disparity in Glucagon-Like Peptide 1 and Inflammation Markers Among Severely Obese Adolescents

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2008English

Effect of Glucagon-Like Peptide 1(7-36) Amide on Glucose Effectiveness and Insulin Action in People With Type 2 Diabetes

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2000English

Effect of Intraportal Glucagon-Like Peptide-1 on Glucose Metabolism in Conscious Dogs

American Journal of Physiology - Endocrinology and Metabolism
EndocrinologyPhysiologyMetabolismDiabetes
2003English

Glucagon-Like Peptide-1 (7-37) Augments Insulin Release in Elderly Patients With Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy